Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.17 (
CaMKII
)
4,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have applied techniques from modern molecular biology and biochemistry to unravel the complex molecular structure of the postsynaptic membrane at glutamatergic synapses in the central nervous system. We have characterized a set of new proteins that are constituents of the postsynaptic density, including PSD-95, densin-180,
citron
(a rho/rac effector protein), and synaptic gp130 Ras GAP (a new Ras GTPase-activating protein). The structure of PSD-95 revealed a new protein motif, the PDZ domain, that plays an important role in the assembly of signal transduction complexes at intercellular junctions. More recently, we have used new imaging tools to observe the dynamics of autophosphorylation of
CaM kinase II
in intact hippocampal tissue. We have been able to detect changes in the amount of autophosphorylated
CaM kinase II
in dendrites, individual synapses, and somas of hippocampal neurons following induction of long-term potentiation by tetanic stimulation. In addition, we have observed a specific increase in the concentration of
CaM kinase II
in dendrites of neurons receiving tetanic stimulation. This increase appears to be the result of dendritic synthesis of new protein. Over the next several years we will apply similar methods to study regulatory changes that occur at the molecular level in glutamatergic synapses in the CNS as the brain processes and stores new information.
...
PMID:Signal transduction molecules at the glutamatergic postsynaptic membrane. 965 38
Synaptic NMDA-type glutamate receptors are anchored to the second of three PDZ (PSD-95/Discs large/ZO-1) domains in the postsynaptic density (PSD) protein PSD-95. Here, we report that
citron
, a protein target for the activated form of the small GTP-binding protein Rho, preferentially binds the third PDZ domain of PSD-95. In GABAergic neurons from the hippocampus,
citron
forms a complex with PSD-95 and is concentrated at the postsynaptic side of glutamatergic synapses. Citron is expressed only at low levels in glutamatergic neurons in the hippocampus and is not detectable at synapses onto these neurons. In contrast to
citron
, p135 SynGAP, an abundant synaptic Ras GTPase-activating protein that can bind to all three PDZ domains of PSD-95, and
Ca2+/calmodulin-dependent protein kinase II
(
CaM kinase II
) are concentrated postsynaptically at glutamatergic synapses on glutamatergic neurons.
CaM kinase II
is not expressed and p135 SynGAP is expressed in less than half of hippocampal GABAergic neurons. Segregation of
citron
into inhibitory neurons does not occur in other brain regions. For example,
citron
is expressed at high levels in most thalamic neurons, which are primarily glutamatergic and contain
CaM kinase II
. In several other brain regions,
citron
is present in a subset of neurons that can be either GABAergic or glutamatergic and can sometimes express
CaM kinase II
. Thus, in the hippocampus, signal transduction complexes associated with postsynaptic NMDA receptors are different in glutamatergic and GABAergic neurons and are specialized in a way that is specific to the hippocampus.
...
PMID:Citron binds to PSD-95 at glutamatergic synapses on inhibitory neurons in the hippocampus. 987 Sep 42